Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben Bjerregaard Larsen

Showing results (41-50 of 185) with videos related to

Pageof 19
Sort By:
Current Opinion in Cardiology|July 15, 2015
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemicsIda Ehlers Albertsen, Thure Filskov Overvad, Gregory Y H Lip, et al.
Cancer Medicine|February 16, 2019
Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort studyMette Søgaard, Peter Brønnum Nielsen, Flemming Skjøth, et al.
Ugeskrift for Laeger|June 2, 2011
[Statins can maybe reduce the risk of venous thromboembolism]Anne Pernille Toft-Petersen, Reimar Wernich Thomsen, Erik Berg Schmidt, et al.
The American Journal of Medicine|November 19, 2021
First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort StudyMette Søgaard, Flemming Skjøth, Peter Brønnum Nielsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 22, 2023
Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillationMette Søgaard, Anne Gulbech Ording, Flemming Skjøth, et al.
International Journal of Cardiology|November 24, 2015
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillationMaura Marcucci, Flemming Skjøth, Gregory Y H Lip, et al.
Journal of Personalized Medicine|June 28, 2023
Positive Prediction Value of Retinal Artery Occlusion Diagnoses in the Danish National Patient Registry: A Validation StudyMarie Ørskov, Tobias Primdahl Holst Nissen, Henrik Vorum, et al.
Expert Review of Cardiovascular Therapy|April 12, 2020
Extended oral anticoagulation after incident venous thromboembolism - a paradigm shift?Ida Ehlers Albertsen, Gregory Piazza, Mette Søgaard, et al.
Critical Care (London, England)|March 20, 2010
Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trialSian Robinson, Aleksander Zincuk, Thomas Strøm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2019
Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish Nationwide CohortPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, et al.
Pageof 19

Showing results (41-50 of 185) with videos related to

Sort By:
Pageof 19
Current Opinion in Cardiology|July 15, 2015
Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemicsIda Ehlers Albertsen, Thure Filskov Overvad, Gregory Y H Lip, et al.
Cancer Medicine|February 16, 2019
Risk of recurrence and bleeding in patients with cancer-associated venous thromboembolism treated with rivaroxaban: A nationwide cohort studyMette Søgaard, Peter Brønnum Nielsen, Flemming Skjøth, et al.
Ugeskrift for Laeger|June 2, 2011
[Statins can maybe reduce the risk of venous thromboembolism]Anne Pernille Toft-Petersen, Reimar Wernich Thomsen, Erik Berg Schmidt, et al.
The American Journal of Medicine|November 19, 2021
First Trimester Anticoagulant Exposure and Adverse Pregnancy Outcomes in Women with Preconception Venous Thromboembolism: A Nationwide Cohort StudyMette Søgaard, Flemming Skjøth, Peter Brønnum Nielsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 22, 2023
Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillationMette Søgaard, Anne Gulbech Ording, Flemming Skjøth, et al.
International Journal of Cardiology|November 24, 2015
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillationMaura Marcucci, Flemming Skjøth, Gregory Y H Lip, et al.
Journal of Personalized Medicine|June 28, 2023
Positive Prediction Value of Retinal Artery Occlusion Diagnoses in the Danish National Patient Registry: A Validation StudyMarie Ørskov, Tobias Primdahl Holst Nissen, Henrik Vorum, et al.
Expert Review of Cardiovascular Therapy|April 12, 2020
Extended oral anticoagulation after incident venous thromboembolism - a paradigm shift?Ida Ehlers Albertsen, Gregory Piazza, Mette Søgaard, et al.
Critical Care (London, England)|March 20, 2010
Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trialSian Robinson, Aleksander Zincuk, Thomas Strøm, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2019
Effectiveness and safety of edoxaban in patients with atrial fibrillation: data from the Danish Nationwide CohortPeter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, et al.
Pageof 19